期刊文献+

D2-40和生存素在宫颈癌中的表达及与预后的相关性 被引量:3

Expression of D2-40 and survivin in Cervical Carcinoma and Their Relation to Prognosis
下载PDF
导出
摘要 目的研究D2-40和生存素(survivin)在宫颈癌中的表达及与预后的相关性。方法采用免疫组织化学方法检测97例宫颈癌中D2-40、survivin的表达,对D2-40标记的LVD进行图像分析。对有随访结果的56例作单、多因素相关生存分析。研究设宫颈上皮内瘤变、慢性炎作为对照组。结果 D2-40标记的LVD值及survivin表达在三组中差异均有统计学意义(P<0.01)。D2-40、survivin在宫颈癌中的表达与浸润深度、组织学类型、FIGO分期及淋巴结转移呈正相关(P<0.01)。D2-40的表达与sur-vivin蛋白的表达呈正相关(P<0.01)。在随访的56例中,单因素分析显示:宫颈癌中D2-40标记的LVD、survivin表达、浸润深度、组织学类型、FIGO分期及淋巴结转移均与患者生存率有关,多因素Cox比例风险分析显示除浸润深度外均具有独立的预后意义。结论 D2-40在宫颈癌组织中高表达,提示D2-40与宫颈癌的发生、发展及转移密切相关。D2-40的表达与宫颈癌组织中survivin蛋白的表达密切相关。两者均是影响宫颈癌预后的因素,并有独立的预后意义。 Objective To investigate the expression of D2-40 and survivin protein in cervical carcinoma and its relation to prognosis.Methods The expression of D2-40 and survivin protein in 97 cases of cervical carcinoma were investigated immunohistochemically,and average LVD marked by D2-40 antibody were examined by computer.Fifty six cases were followed up,in which the prognosis was studied with both univariate and multivariate analysis.The cases of cervical intraepithelial neoplasia,chronic cervicitis were compared in the investigation.Results The average LVD marked by D2-40 and expression of survivin protein were obviously different among three groups(P0.01).D2-40 and survivin protein expression were associated with differentiated grade,aggressive degree,FIGO stage and lymph nodal involvement(P0.01).The expression of D2-40 was positively associated with survivin protein(P0.01).In the 56 cases with followed-up data,univariant analysis revealed that the average LVD marked by D2-40,expression of survivin,differentiated grade,aggressive degree,FIGO stage and lymph nodal involvement were correlated with the survival rate.Cox stepwise proportional hazards analysis showed that they were prognostic factors independently except aggressive degree.Conclusion D2-40 was highly expressed in cervical carcinoma,which suggested that D2-40 was closely related to the growth,development and metastasis of cervical carcinoma.And there was intimate correlation between expression of D2-40 and survivin protein in cervical carcinoma.They were independent prognostic factors independently.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2012年第3期307-311,共5页 Cancer Research on Prevention and Treatment
关键词 D2-40 生存素 宫颈癌 免疫组织化学 预后 D2-40 survivin Cervical carcinoma Immunohistochemistry Prognosis
  • 相关文献

参考文献9

  • 1Choi WW,Lewis MM,Lawson D,et al.Angiogenic and lymphangiogenic microvessel density in breast carcinoma:correlationwith clinicopathologic parameters and VEGF-family gene ex-pression[J].Mod Pathol,2005,18(1):143-152.
  • 2Stauber RH,Mann W,Knauer SK.Nuclear and cytoplasmicsurvivin:molecular mechanism,prognostic,and therapeutic po-tential[J].Cancer Res,2007,67(13):5999-6002.
  • 3朱燕,杨其昌,刘宏斌,刘曼华,沈屹,张晓娟.人缺氧诱导因子1α与CD105在宫颈癌中的表达及意义[J].中华病理学杂志,2008,37(4):264-265. 被引量:4
  • 4Weidner N.Current pathologic methods for measuring intratu-moral microvessel density within breast carcinoma and othersolid tumors[J].Breast Cancer Res Treat,1995,36(2):169-180.
  • 5谢晓冬,屈淑贤,郑振东,刘大为.人乳腺癌中D2-40标记的微淋巴管密度与淋巴结转移关系的研究[J].中国肿瘤临床,2008,35(14):810-813. 被引量:11
  • 6Gombos Z,Xu X,Chu CS,et al.Peritumoral lymphatic vesseldensity and vascular endothelial growth factor C expression inearly-stage squamous cell carcinoma of the uterine cervix[J].Clin Cancer Res,2005,11(23):8364-8371.
  • 7Kaneko I,Tanaka S,Oka S,et al.Lymphatic vessel density atthe site of deepest penetration as a predictor of lymph node me-tastasis in submucosal colorectal cancer[J].Dis Colon Rectum,2007,50(1):13-21.
  • 8Kim HS,Shiraki K,Park SH.Expression of survivin in CINandinvasive squamous cell carcinoma of uterine cervix[J].Anticancer Res,2002,22(2A):805-808.
  • 9朱燕,杨其昌,刘宏斌,张晓娟,沈屹.survivin、bcl-2及p53蛋白在宫颈上皮内瘤变和宫颈癌组织中的表达及意义[J].实用癌症杂志,2008,23(2):138-140. 被引量:10

二级参考文献30

共引文献21

同被引文献28

  • 1李隆玉,李诚信.宫颈癌的预防及普查[J].继续医学教育,2005,19(5):43-45. 被引量:8
  • 2张梅娟,张丽华.免疫标记物D2-40在病理诊断中的应用和意义[J].诊断学理论与实践,2007,6(3):277-280. 被引量:20
  • 3Seccareecia E, Brodt P. The role of the inlinre ceptor in malignancy: an update [ J]. Growth HQrm IGF Res,2012, 22(6) :193-199.
  • 4Da MX, Wu Z, Tian HW. Tumor lymphangiogenesis and |ymphangio- genic growth factors[ J ]. Arch Med Res,2008,39 (4) : 365-372.
  • 5Ji RC. Lymphatic endothelial cells, lymphangiogenesis, and extracel- lular matrix [J]. Lymph Res Biol,2006,4(2) :83-100.
  • 6Gao J, Chang YS, Jallal B, et al. Targeting the insulin-like growth fac- tor axis for the development of novel therapeutics in oncology [ J ]. Cancer Res,2012,72( 1 ) :3-12.
  • 7Xiong Y, Cao LP, Rao HL, et al. Clinical significance of peritumoral lymphatic vessel density and lymphatic vessel in- vasion detected by D2 - 40 immunostaining in FIGO Ⅰbl - Ⅱa squamous cell cervical cancer. Cell Tissue Res, 2012, 348: 515 - 522.
  • 8Mitsuhashi A, Suzuka K, Yamazawa K, et al. Serum vascu- lar endothelial growth factor (VEGF) and VEGF- C levels as tumormarkers in patientswith cervical carcinoma. Cancer, 2005, 103: 724-730.
  • 9Sotiropoulou N, Bravou V, Kounelis S, et al. Tumour ex- pression of lymphangiogenic growth factors but not lymphatic vessel density is implicated in human cervical cancer progres- sion. Pathology, 2010, 42: 629- 636.
  • 10Achen MG, Stacker SA. Vascular endothelial growth factor- D: signaling mechanisms, biology, and clinical relevance. Growth Factors, 2012, 30.. 283-296.

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部